The National Cancer Institute (NCI) is offering a grant to support research in cancer etiology and early detection biomarkers, making use of the unique PLCO Biospecimens Resource. This grant aims to utilize the high-quality, prospectively collected biospecimens from the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial, including pre-diagnostic blood samples and buccal cells. Research proposals should focus on biochemical and genetic analyses of cancer risk, as well as the discovery and validation of early detection biomarkers. Projects must involve utilizing PLCO biospecimens and leveraging their unique characteristics to bridge gaps in cancer research. Applications not utilizing PLCO biospecimens will not be considered. Application deadline is Aug 15, 2018.
Opportunity ID: 277820
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-15-297 |
| Funding Opportunity Title: | Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 15, 2018 |
| Current Closing Date for Applications: | Aug 15, 2018 |
| Archive Date: | Sep 15, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts State governments Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Public housing authorities/Indian housing authorities City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-15-297.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00217808 | Jan 17, 2016 | Jun 07, 2016 | View | |
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00223995 | Jul 16, 2016 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00235556 | Nov 01, 2017 | Aug 15, 2018 | View |
Package 1
Mandatory forms
277820 RR_SF424_2_0-2.0.pdf
277820 PHS398_ResearchPlan_2_0-2.0.pdf
277820 PHS398_CoverPageSupplement_2_0-2.0.pdf
277820 RR_KeyPersonExpanded_2_0-2.0.pdf
277820 RR_OtherProjectInfo_1_3-1.3.pdf
277820 PerformanceSite_2_0-2.0.pdf
Optional forms
277820 RR_SubawardBudget30_1_3-1.3.pdf
277820 PlannedReport-1.0.pdf
277820 PHS398_CumulativeInclusionReport-1.0.pdf
277820 PHS398_ModularBudget_1_2-1.2.pdf
277820 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
277820 RR_SF424_2_0-2.0.pdf
277820 PHS398_CoverPageSupplement_3_0-3.0.pdf
277820 RR_OtherProjectInfo_1_3-1.3.pdf
277820 PerformanceSite_2_0-2.0.pdf
277820 RR_KeyPersonExpanded_2_0-2.0.pdf
277820 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
277820 RR_Budget_1_3-1.3.pdf
277820 RR_SubawardBudget30_1_3-1.3.pdf
277820 PHS398_ModularBudget_1_2-1.2.pdf
277820 PHS_Inclusion_Enrollment_Report-1.0.pdf
277820 PHS_AssignmentRequestForm-1.0.pdf
Package 3
Mandatory forms
277820 RR_SF424_2_0-2.0.pdf
277820 PHS398_CoverPageSupplement_4_0-4.0.pdf
277820 RR_OtherProjectInfo_1_4-1.4.pdf
277820 PerformanceSite_2_0-2.0.pdf
277820 RR_KeyPersonExpanded_2_0-2.0.pdf
277820 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
277820 RR_Budget_1_4-1.4.pdf
277820 RR_SubawardBudget30_1_4-1.4.pdf
277820 PHS398_ModularBudget_1_2-1.2.pdf
277820 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
